Agfa-Gevaert N.V.

Agfa-Gevaert N.V.

AFGVY
Agfa-Gevaert N.V.US flagOther OTC
2.29
USD
- -
- -
88.63MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
34.16
31.24
31.55
30.25
29.13
26.12
23.55
20.38
22.53
14.66
14.86
14.7
14.03
13.99
Basic EPS, GAAP
0.49
0.6
0.74
0.83
0.44
-0.29
-0.63
7.31
-0.22
-2.83
-1.32
-1.19
-0.92
-0.8
Free Cash Flow per Basic Share
0.8
1.36
1.34
1.17
-0.07
-0.52
1.47
-1.82
-1.48
-1.28
-0.39
-0.05
0.81
0.56
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
10.15
10.68
11.42
12.26
12.7
12.41
11.8
19.06
18.83
15.73
14.62
13.42
13.14
13.01
Tangible Book Value per Share
-2.98
-5.59
-4.22
-4.4
-3.36
-3.89
-6.1
3.4
4.4
3.6
1.76
0.76
-0.16
0.05
Basic Weighted Avg Shares
84
84
84
84
84
84
84
84
78
78
77
77
77
77
Sales/Revenue/Turnover
2,865
2,620
2,646
2,537
2,443
2,191
1,975
1,709
1,760
1,145
1,150
1,138
1,086
1,080
Operating Margin (%)
7.71
6.15
6.76
7.69
6.22
3.33
3.14
1.4
1.14
-3.32
0.43
0.97
0.74
-2.78
Depreciation Expense
86
69
61
72
56
54
94
69
62
63
42
42
36
36
Net Income, GAAP
41
50
62
70
37
-24
-53
613
-17
-221
-102
-92
-71
-62
Effective Tax Rate (%)
46.74
23.38
18.39
30.43
54.08
154.55
- -
- -
1,500
- -
- -
- -
- -
3.12
Profit Margin (%)
1.43
1.91
2.34
2.76
1.51
-1.1
-2.68
35.87
-0.97
-19.3
-8.87
-8.08
-6.54
-5.74
Working Capital
699
550
567
568
563
607
473
952
742
568
404
397
316
336
LT Debt
319
125
137
74
47
219
224
54
46
41
68
141
152
184
Total Equity
368
146
268
252
307
290
130
621
686
561
396
325
256
246
Return on Invested Capital (%)
16.72
18.18
25.49
26.86
14.91
-7.05
- -
- -
-35.78
- -
- -
- -
- -
- -
Return on Capital (%)
5.28
6.51
7.12
7.52
3.98
-4.35
- -
- -
-13.03
- -
- -
- -
- -
-3.33
Return on Common Equity (%)
4.94
5.72
6.69
7.05
3.54
-2.28
-5.22
47.35
-1.11
-16.37
-8.64
-8.48
-6.91
-6.13

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
14
17
12
LT Borrowings
131
111
141
LT Finance Leases
32
41
43
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
155
155
155
Market Capitalization
182
152
153

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
725
719
726
Cash, Cash Equivalents & STI
65
91
84
Accounts Receivable, Net
148
169
143
Inventories
305
254
330
Total Current Liabilities
359
403
390
Payables & Accruals
- -
- -
- -
ST Debt
14
17
12
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
25.65%
-15.26%
-21.23%
Free Cash Flow
-195.89%
-373.93%
-1,675%
Net Income, GAAP
-32.41%
202.15%
-22.83%
Sales/Revenue/Turnover
-7.86%
-7.43%
-4.57%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
250
286
277
325
1,138
2025
242
281
257
306
1,086
2026
236
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.28
0.06
-0.16
-0.8
-1.19
2025
-0.26
- -
-0.24
-0.8
-0.92
2026
-0.16
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Pascal Juery
Full Time Employees
4,765
Sector
Industrials
Industry
Industrial - Machinery
Address
Septestraat 27 Mortsel Belgium 2640
IPO Date
Aug 3, 2012
Website
agfa.com
Business
Agfa-Gevaert N.V. Agfa-Gevaert NV (AFGVY) develops, produces and distributes analogue and digital imaging systems and IT solutions primarily for the printing industry, healthcare sector and specific industrial applications; its core offerings span Digital Print & Chemicals, including wide-format inkjet printers such as the Anapurna and Avanti series, workflow software like Asanti, dedicated inks, cutting machines, inkjet media and pressroom chemicals; Radiology Solutions, encompassing digital radiography systems, computed radiography, direct radiography flat panels, X-ray films, hardcopy films, printers, MUSICA image processing software and SmartXR intelligent workflow assistants; HealthCare IT, featuring the Enterprise Imaging Platform with cloud and SaaS solutions, XERO Universal Viewer, PACS systems, reporting tools, cardiology applications, data storage and AI-enhanced imaging; and Specialty Products such as ZIRFON electrolysis membranes for green hydrogen production, synthetic paper, industrial imaging films for printed circuit boards and non-destructive testing, aerial photography films, industrial foils, conductive materials and ID security solutions. Headquartered in Mortsel, Belgium, the company was founded in 1867 through the origins of Agfa in Germany and Gevaert in Belgium, which merged in 1964, and operates production facilities in nine countries including Belgium, the United States, Canada, Germany, Austria, China and Brazil, with sales presence in over 40 countries worldwide. Recent developments include a strategic reorganization announced for January 1, 2026, to streamline into three distinct business segments focused on growth areas; strengthened partnerships such as with Rad AI for radiology workflows, Med-XRay as a distribution partner in Portugal, Alliance Medical for Enterprise Imaging in the UK, EFI for digital printing equipment and BHS Corrugated for single-pass corrugate printers; new product launches like the Anapurna Ciervo H2050/H2500 printers, high-performance inkjet solutions at FESPA 2025 and advancements in SpeedSet single-pass packaging printers; expansion of cloud/SaaS momentum in HealthCare IT with deals like Englewood Health and PHCC Qatar for DR systems; a July 2025 collaboration with VITO for next-generation green hydrogen membranes; ongoing cost optimization for declining medical film markets with savings expected in late 2025; and positive Q3 2025 free cash flow driven by working capital improvements and the AgfaPhoto arbitration resolution.

Company News

APIChatGPT
  • Agfa-Gevaert NV (AFGVY) Q3 2025 Earnings Call Transcript